Aspiriant LLC’s Amgen AMGN Stock Holding History

Aspiriant LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45M	Sell	4,009 -1,033	-20%	-$354K	0.04%	139
2026 Q1	$1.77M	Buy	5,042 +305	+6%	+$109K	0.05%	121
2025 Q4	$1.55M	Buy	4,737 +262	+6%	+$83.1K	0.04%	132
2025 Q3	$1.26M	Buy	4,475 +64	+1%	+$18.6K	0.04%	128
2025 Q2	$1.23M	Buy	4,411 +47	+1%	+$13.3K	0.04%	134
2025 Q1	$1.36M	Sell	4,364 -68	-2%	-$20.1K	0.05%	119
2024 Q4	$1.16M	Sell	4,432 -6	-0.1%	-$1.78K	0.04%	131
2024 Q3	$1.43M	Sell	4,438 -5	-0.1%	-$1.64K	0.05%	115
2024 Q2	$1.39M	Sell	4,443 -500	-10%	-$147K	0.06%	111
2024 Q1	$1.41M	Sell	4,943 -4	-0.1%	-$1.17K	0.06%	120
2023 Q4	$1.42M	Sell	4,947 -53	-1%	-$14.4K	0.06%	114
2023 Q3	$1.34M	Buy	5,000 +242	+5%	+$60.4K	0.07%	112
2023 Q2	$1.06M	Buy	4,758 +840	+21%	+$195K	0.05%	129
2023 Q1	$947K	Buy	3,918 +285	+8%	+$70K	0.05%	135
2022 Q4	$954K	Buy	3,633 +162	+5%	+$43.4K	0.05%	131
2022 Q3	$783K	Buy	3,471 +162	+5%	+$39.3K	0.04%	136
2022 Q2	$806K	Buy	3,309 +24	+0.7%	+$5.88K	0.04%	136
2022 Q1	$797K	Sell	3,285 -322	-9%	-$74K	0.04%	145
2021 Q4	$810K	Buy	3,607 +478	+15%	+$101K	0.04%	147
2021 Q3	$665K	Buy	3,129 +28	+0.9%	+$6.45K	0.04%	145
2021 Q2	$757K	Buy	3,101 +82	+3%	+$20.2K	0.04%	135
2021 Q1	$752K	Buy	3,019 +964	+47%	+$230K	0.05%	121
2020 Q4	$473K	Buy	2,055 +42	+2%	+$9.68K	0.03%	147
2020 Q3	$509K	Buy	2,013 +7	+0.3%	+$1.73K	0.04%	150
2020 Q2	$473K	Sell	2,006 -820	-29%	-$187K	0.04%	131
2020 Q1	$570K	Buy	2,826 +91	+3%	+$19.9K	0.06%	114
2019 Q4	$657K	Hold	2,735	–	–	0.06%	117
2019 Q3	$532K	Sell	2,735 -449	-14%	-$86.2K	0.05%	141
2019 Q2	$585K	Hold	3,184	–	–	0.05%	137
2019 Q1	$606K	Sell	3,184 -1,535	-33%	-$293K	0.05%	134
2018 Q4	$919K	Sell	4,719 -59	-1%	-$11.5K	0.07%	109
2018 Q3	$991K	Sell	4,778 -121	-2%	-$23.8K	0.08%	108
2018 Q2	$904K	Buy	4,899 +552	+13%	+$97.6K	0.08%	112
2018 Q1	$741K	Buy	4,347 +2,693	+163%	+$494K	0.06%	123
2017 Q4	$288K	Sell	1,654 -2,661	-62%	-$471K	0.08%	66
2017 Q3	$805K	Sell	4,315 -287	-6%	-$50.9K	0.07%	120
2017 Q2	$793K	Sell	4,602 -33	-0.7%	-$5.37K	0.07%	123
2017 Q1	$760K	Buy	4,635 +1,071	+30%	+$178K	0.06%	129
2016 Q4	$521K	Sell	3,564 -517	-13%	-$77.8K	0.05%	133
2016 Q3	$681K	Hold	4,081	–	–	0.07%	124
2016 Q2	$621K	Buy	4,081 +517	+15%	+$80.4K	0.06%	128
2016 Q1	$534K	Sell	3,564 -174	-5%	-$25.9K	0.05%	132
2015 Q4	$607K	Buy	3,738 +174	+5%	+$27.4K	0.07%	52
2015 Q3	$493K	Sell	3,564 -4,375	-55%	-$690K	0.04%	72
2015 Q2	$1.22M	Hold	7,939	–	–	0.12%	41
2015 Q1	$1.27M	Buy	7,939 +3,920	+98%	+$617K	0.16%	33
2014 Q4	$640K	Buy	4,019 +324	+9%	+$50.5K	0.09%	53
2014 Q3	$519K	Buy	3,695 +55	+2%	+$7.18K	0.07%	55
2014 Q2	$431K	Hold	3,640	–	–	0.06%	67
2014 Q1	$449K	Hold	3,640	–	–	0.07%	68
2013 Q4	$415K	Hold	3,640	–	–	0.06%	59
2013 Q3	$407K	Buy	+3,640	New	+$395K	0.07%	36

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Aspiriant LLC's AMGN Position: Q2 2026 in Review

Aspiriant LLC reduced its Amgen (AMGN) stake by 20% in Q2 2026, selling an estimated $354K and leaving 4,009 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #139.

Aspiriant LLC first reported a position in AMGN in Q3 2013 and has held it in 52 quarters since. The position peaked at $1.77M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Aspiriant LLC held 4,009 shares of Amgen worth $1.45M as of Q2 2026.
Aspiriant LLC sold 1,033 Amgen shares in Q2 2026, an estimated $354K.
Amgen made up 0.04% of Aspiriant LLC's portfolio in Q2 2026, its #139 holding.
Aspiriant LLC first reported a position in Amgen in Q3 2013 and has held it in 52 quarters since.
Aspiriant LLC's Amgen position peaked at $1.77M in Q1 2026.
1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.